Original Article
Copyright ©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Mar 21, 2011; 17(11): 1448-1456
Published online Mar 21, 2011. doi: 10.3748/wjg.v17.i11.1448
How we can improve patients’ comfort after Milligan-Morgan open haemorrhoidectomy
Ma-Mu-Ti-Jiang A ba-bai-ke-re, Hong-Guo Huang, Wen-Ni Re, Kai Fan, Hui Chu, Er-Ha-Ti Ai, Mai-Mai-Ti-Tu-Er-Xun KE Li-Mu, Yi-Rui Wang, Hao Wen
Ma-Mu-Ti-Jiang A ba-bai-ke-re, Hong-Guo Huang, Kai Fan, Hui Chu, Er-Ha-Ti Ai, Department of Anorectal Surgical, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, Xinjiang Uygur Autonomous Region, China
Wen-Ni Re, Department of Otolaryngeological, Urumqi General Hospital, Lanzhou Military Command, Urumqi 830011, Xinjiang Uygur Autonomous Region, China
Mai-Mai-Ti-Tu-Er-Xun KE Li-Mu, Yi-Rui Wang, Department of Pharmocological, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, Xinjiang Uygur Autonomous Region, China
Hao Wen, Digestive and Vascular Surgical Center, First Affiliated Hospital, Xinjiang Medical University, Urumqi 830011, Xinjiang Uygur Autonomous Region, China
Author contributions: A ba-bai-ke-re MMTJ contributed to the conception and design of this trial and drafted the manuscript; Huang HG performed the research, collected and recorded data and gave final approval of the article; Chu H Wen H, Fan K and Ai EHT analyzed and interpreted the data; Wen H revised the article; Re WN, KE Li-Mu MMTTEX and Wang YR contributed to intervention control and observed the side effects of Diosmin; all authors read and approved the final manuscript.
Supported by The Biological Medical Engineering Foundation of First Affiliated Hospital of Xinjiang Medical University
Correspondence to: Ma-Mu-Ti-Jiang A ba-bai-ke-re, MD, Department of Anorectal Surgical, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, Xinjiang Uygur Autonomous Region, China. mamutjan206@sina.com
Telephone: +86-991-4366142 Fax: +86-991-4366062
Received: September 14, 2010
Revised: December 9, 2010
Accepted: December 16, 2010
Published online: March 21, 2011
Abstract

AIM: To demonstrate the value of Diosmin (flavonidic fraction) in the management of post-haemorhoidectomic symptoms.

METHODS: Eighty-six consecutive patients with grades III and IV acute mixed hemorrhoids admitted to the Anorectal Surgical Department of First Affiliated Hospital, Xinjiang Medical University from April 2009 to April 2010, were enrolled in this study. An observer-blinded, randomized trial was conducted to compare post-haemorhoidectomic symptoms with use of Diosmin flavonidic fraction vs placebo. Eighty-six patients were randomly allocated to receive Diosmin flavonidic fraction 500 mg for 1 wk (n = 43) or placebo (n = 43). The Milligan-Morgan open haemorrhoidectomy was performed by a standardized diathermy excision method. Pain, bleeding, heaviness, pruritus, wound edema and mucosal discharge were observed after surgery. The postoperative symptoms and hospitalization time were recorded.

RESULTS: The mean age of the Diosmin group and controls was 53.2 and 51.3 years, respectively. In Diosmin group, haemorrhoid piles were of the third degree in 33 patients and the fourth degree in 10; and in the control group, 29 were of the third degree and 14 were of the fourth degree. There was no statistically significance in age, gender distribution, degree and number of excised haemorrhoid piles, and the mean duration of haemorrhoidal disease between the two groups. There was a statistically significant improvement in pain, heaviness, bleeding, pruritus from baseline to the 8th week after operation (P < 0.05). Patients taking Diosmin had a shorter hospitalization stay after surgery (P < 0.05). There was also a significant improvement on the proctoscopic appearance (P < 0.001). However, there was no statistical difference between the two groups in terms of wound mucosal discharge. Two patients experienced minor bleeding at the 8th week in Diosmin group, and underwent surgery.

CONCLUSION: Diosmin is effective in alleviating postoperational symptoms of haemorrhoids. Therefore, it should be considered for the initial treatment after haemorrhoid surgery. However, further prospective randomized trials are needed to confirm the findings of this study.

Keywords: Flavonidic fraction, Postoperative complication, Haemorrhoids